72623473 : It's no use; insiders will deliberately cause all kinds of trouble! Like a fire, like a leak, etc... then they go back to the bottom! Full of routines...

Steven J : I bought  $Concentrix (CNXC.US)$ ,$Advanced Micro Devices (AMD.US)$  at these low levels. Sold my $Axcelis Technologies (ACLS.US)$ at 136. I like that one too. But here one of my favorite and is very undervalued $Certara (CERT.US)$ and unappreciated by wallstreet.
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. The pipeline of getting drugs approved keeps going up and Biosimulation should be beneficiary. Do your own Homework

I am 102702622 : Why would you consider buying a 3rd grade semiconductor stock when there are better buys out there like ASML ?

Sikander KHAN OP I am 102702622 : Thank you for your comment. No one is 100% right in the marker even Buffett. Anyways, allow me to provide some clarification regarding my investment approach. I am a long-term investor, with an investment horizon of at least 10 years or more. I do not select companies based on momentum, nor do I make purchases solely focused on individual companies. My investment decisions are guided by the specific needs of my portfolio.
My stock selections are grounded in thorough research, analysis of market sentiment, growth potential, and, most importantly, the integrity of company management. The stock in question has been part of my portfolio from an earlier, lower price point and has already yielded significant returns. Nonetheless, I am continuing to add to my position at the current price level.
Regarding ACML, it has been a part of my portfolio since 2015, and I don’t have any plan to sell it for next 10 more years. Regarding your question about ACLS, I am confident that my revised new research pick ACLS  will continue to deliver substantial returns over the next 10 years.